Navidea Biopharmaceuticals, Inc.(NYSE Amex Equities : NAVB)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -1.22% | 184.83 | 1.3% | $525.46m | |
| ARRY | Array BioPharma Inc. | 0.07% | 46.23 | 8.1% | $445.22m | |
| CELG | Celgene Corporation | -5.50% | 93.47 | 1.3% | $436.61m | |
| GILD | Gilead Sciences, Inc. | -0.78% | 68.84 | 0.9% | $401.57m | |
| BIIB | Biogen Inc. | -1.33% | 235.91 | 1.3% | $365.47m | |
| ILMN | Illumina, Inc. | -1.06% | 357.74 | 3.5% | $308.47m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.41% | 312.55 | 2.6% | $248.34m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.60% | 181.02 | 1.9% | $220.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -4.09% | 126.98 | 2.0% | $208.95m | |
| EXAS | Exact Sciences Corporation | -1.63% | 113.77 | 24.1% | $194.49m | |
| A | Agilent Technologies, Inc. | -0.29% | 73.13 | 1.6% | $161.67m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.29% | 85.90 | 4.3% | $132.28m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.96% | 127.34 | 14.7% | $115.63m | |
| INCY | Incyte Corporation | -2.01% | 86.92 | 2.5% | $115.49m | |
| MRTX | Mirati Therapeutics Inc. | -0.68% | 100.75 | 2.5% | $104.36m |
Company Profile
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.